X
IONS icon

Xponance’s Ionis Pharmaceuticals IONS Stock Holding History

Xponance’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Buy
26,384
+3,443
+15% +$272K 0.01% 574
2025
Q4 		$1.81M Buy
22,941
+1,491
+7% +$112K 0.01% 561
2025
Q3 		$1.4M Sell
21,450
-1,304
-6% -$63.7K 0.01% 627
2025
Q2 		$899K Buy
22,754
+2,435
+12% +$79.7K 0.01% 728
2025
Q1 		$613K Buy
20,319
+980
+5% +$32.1K 0.01% 871
2024
Q4 		$676K Buy
19,339
+318
+2% +$11.9K 0.01% 855
2024
Q3 		$762K Buy
19,021
+906
+5% +$42.2K 0.01% 797
2024
Q2 		$863K Buy
18,115
+1,906
+12% +$78.2K 0.01% 722
2024
Q1 		$703K Sell
16,209
-484
-3% -$23.1K 0.01% 835
2023
Q4 		$844K Sell
16,693
-1,143
-6% -$54.7K 0.01% 733
2023
Q3 		$809K Sell
17,836
-430
-2% -$17.7K 0.01% 713
2023
Q2 		$749K Buy
18,266
+339
+2% +$13K 0.01% 754
2023
Q1 		$641K Buy
17,927
+217
+1% +$8.15K 0.01% 827
2022
Q4 		$669K Buy
17,710
+2,170
+14% +$91.3K 0.01% 789
2022
Q3 		$687K Buy
15,540
+122
+0.8% +$5.14K 0.01% 706
2022
Q2 		$571K Buy
15,418
+520
+3% +$19.6K 0.01% 808
2022
Q1 		$552K Buy
14,898
+8
+0.1% +$262 0.01% 860
2021
Q4 		$453K Buy
14,890
+318
+2% +$10K 0.01% 938
2021
Q3 		$489K Sell
14,572
-654
-4% -$24.6K 0.01% 899
2021
Q2 		$607K Buy
15,226
+8,423
+124% +$330K 0.01% 821
2021
Q1 		$306K Buy
6,803
+23
+0.3% +$1.28K 0.01% 955
2020
Q4 		$383K Buy
6,780
+209
+3% +$10.4K 0.01% 866
2020
Q3 		$312K Sell
6,571
-215
-3% -$11.9K 0.01% 842
2020
Q2 		$400K Buy
+6,786
New +$377K 0.01% 707

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Xponance's IONS Position: Q1 2026 in Review

Xponance increased its Ionis Pharmaceuticals (IONS) stake by 15% in Q1 2026, buying an estimated $272K and bringing the position to 26,384 shares worth $1.98M. The position accounts for 0.01% of the portfolio, ranked #574.

Xponance first reported a position in IONS in Q2 2020 and has held it in 24 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Xponance held 26,384 shares of Ionis Pharmaceuticals worth $1.98M as of Q1 2026.
  • Xponance bought 3,443 Ionis Pharmaceuticals shares in Q1 2026, an estimated $272K.
  • Ionis Pharmaceuticals made up 0.01% of Xponance's portfolio in Q1 2026, its #574 holding.
  • Xponance first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.